SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: harkenman who wrote (78)3/25/1997 2:23:00 PM
From: KurtVedder   of 998
 
Harkenman, save your breath. If you read my posts I said the same thing. The European trials did not confirm the results. As a matter of fact, the European trial was a downright dud! But if you saw the post-hoc analysis presented in Chicago in January along with the new information included in the NDA you will see why the PCNS Committee of the FDA unanumously approved Myotrophin for T-IND last year, and will do the same this year. Read my posts on the Motley Fool board. Now, why don't we wait until May 8th and see who is right? You can laugh at me and say "I told you so!" on May 9th. Or maybe not.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News